These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 27285718)

  • 41. Resistance to glycopeptide antibiotics in the teicoplanin producer is mediated by van gene homologue expression directing the synthesis of a modified cell wall peptidoglycan.
    Beltrametti F; Consolandi A; Carrano L; Bagatin F; Rossi R; Leoni L; Zennaro E; Selva E; Marinelli F
    Antimicrob Agents Chemother; 2007 Apr; 51(4):1135-41. PubMed ID: 17220405
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Production of teicoplanin by valine analogue-resistant mutant strains of Actinoplanes teichomyceticus.
    Jin ZH; Wang MR; Cen PL
    Appl Microbiol Biotechnol; 2002 Jan; 58(1):63-6. PubMed ID: 11833531
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Glycopeptide and daptomycin susceptibility trends among clinical isolates of methicillin-resistant Staphylococcus aureus in a tertiary care center in North India.
    Singh A; Prasad KN; Rai RP; Singh SK; Rahman M; Tripathi A; Srivastava JK
    J Infect Public Health; 2015; 8(4):341-5. PubMed ID: 25797814
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The in vitro activity of ramoplanin (A-16686/MDL 62,198), vancomycin and teicoplanin against methicillin-susceptible and methicillin-resistant Staphylococcus spp.
    O'Hare MD; Felmingham D; Grüneberg RN
    Drugs Exp Clin Res; 1988; 14(10):617-9. PubMed ID: 2977587
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Synergy study of vancomycin or teicoplanin plus gentamicin against enterococci, Staphylococcus aureus and coagulase-negative staphylococci by time-kill method.
    Thamlikitkul V
    J Med Assoc Thai; 1991 Dec; 74(12):669-74. PubMed ID: 1839906
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Time-kill kinetics of oritavancin and comparator agents against Staphylococcus aureus, Enterococcus faecalis and Enterococcus faecium.
    McKay GA; Beaulieu S; Arhin FF; Belley A; Sarmiento I; Parr T; Moeck G
    J Antimicrob Chemother; 2009 Jun; 63(6):1191-9. PubMed ID: 19369269
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Influence of inoculum size on MICs for methicillin-susceptible Staphylococcus aureus and methicillin-resistant Staphylococcus aureus].
    Miyake N; Kadowaki M; Sato Y; Eriguchi Y; Nagasaki Y; Harada Y; Uchida Y; Shimono N
    Jpn J Antibiot; 2011 Aug; 64(4):231-7. PubMed ID: 22066347
    [TBL] [Abstract][Full Text] [Related]  

  • 48. In vitro activity of dalbavancin against staphylococci isolated in Istanbul, Turkey.
    Aktas G; Derbentli S
    Chemotherapy; 2010; 56(6):444-7. PubMed ID: 21088395
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparative In Vitro Activities of Oritavancin, Dalbavancin, and Vancomycin against Methicillin-Resistant Staphylococcus aureus Isolates in a Nondividing State.
    Belley A; Lalonde Seguin D; Arhin F; Moeck G
    Antimicrob Agents Chemother; 2016 Jul; 60(7):4342-5. PubMed ID: 27067327
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Actinoplanes teichomyceticus ATCC 31121 as a cell factory for producing teicoplanin.
    Taurino C; Frattini L; Marcone GL; Gastaldo L; Marinelli F
    Microb Cell Fact; 2011 Oct; 10():82. PubMed ID: 22008254
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Increased uptake and improved intracellular survival of a teicoplanin-resistant mutant of methicillin-resistant Staphylococcus aureus in non-professional phagocytes.
    Renzoni A; Huggler E; Kelley WL; Lew D; Vaudaux P
    Chemotherapy; 2009; 55(3):183-8. PubMed ID: 19407446
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Methicillin-resistant Staphylococcus aureus in North-east Croatia.
    Pastuović T; Perić M; Bošnjak Z; Ružman N; Majić PR; Talapko J; Atalić V; Loci-Zvocak S; Vuković D
    Acta Med Acad; 2015; 44(1):10-7. PubMed ID: 26062693
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Reliability of disc-diffusion susceptibility testing for arbekacin, vancomycin and teicoplanin against methicillin-resistant Staphylococcus aureus].
    Kouda M; Homma S; Udagawa I; Tamura K; Fukuhara J; Takeuchi M
    Jpn J Antibiot; 1999 Dec; 52(12):681-9. PubMed ID: 10695023
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Evaluation of susceptibility of methicillin resistant Staphylococcus aureus strains to vancomycin].
    Młynarczyk G; Młynarczyk A; Meisel-Mikołajczyk F
    Med Dosw Mikrobiol; 1995; 47(3-4):133-9. PubMed ID: 8833924
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Rational selection and engineering of exogenous principal sigma factor (σ(HrdB)) to increase teicoplanin production in an industrial strain of Actinoplanes teichomyceticus.
    Wang H; Yang L; Wu K; Li G
    Microb Cell Fact; 2014 Jan; 13():10. PubMed ID: 24428890
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Infectivity-resistotype-genotype clustering of methicillin-resistant Staphylococcus aureus strains in the Central Blacksea Region of Turkey].
    Kırca Yılmaz S; Acuner IC; Strommenger B; Bek Y; Witte W
    Mikrobiyol Bul; 2014 Jan; 48(1):14-27. PubMed ID: 24506712
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Activity of vancomycin and teicoplanin against clinical isolates of Staphylococcus aureus in the period 1994-1999].
    Nashev D; Toshkova K; Gavrilova V
    Vutr Boles; 2000; 32(2):35-40. PubMed ID: 11227664
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Incidence, frequency and resistance characteristics of methicillin-oxacillin resistant Staphylococcus aureus strains in Germany].
    Voss A; Machka K; Lenz W; Milatovic D
    Dtsch Med Wochenschr; 1992 Dec; 117(50):1907-12. PubMed ID: 1459021
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Sensitivity of methicillin resistant staphylococci to linezolid and some other antimicrobial agents].
    Ertek M; Yazgi H; Aktaş E; Ayyildiz A; Parlak M
    Mikrobiyol Bul; 2003 Oct; 37(4):235-40. PubMed ID: 14748259
    [TBL] [Abstract][Full Text] [Related]  

  • 60. In vitro combined effects of cefozopran/teicoplanin and cefozopran/vancomycin on methicillin-resistant Staphylococcus aureus.
    Toyokawa M; Asari S; Nishi I; Horikawa M; Tsukamoto H; Sunada A; Ueda A; Iwatani Y
    J Chemother; 2003 Feb; 15(1):31-6. PubMed ID: 12678411
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.